HTG Molecular Diagnostics, Inc. Proceeds from Stock Plans
HTG Molecular Diagnostics, Inc. reported Proceeds from Stock Plans of $37.57 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2023-03-30
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for the quarter ending 2022-12-31 was $14.24K, a 80.33% decline year-over-year.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for the quarter ending 2022-09-30 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for the quarter ending 2021-12-31 was $72.39K, a 356.93% increase year-over-year.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for the quarter ending 2021-09-30 was $0.00.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for fiscal 2022 was $37.57K, a 70.14% decline from fiscal 2021.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for fiscal 2021 was $125.83K, a 207.08% increase from fiscal 2020.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for fiscal 2020 was $40.98K, a 60.96% decline from fiscal 2019.
- HTG Molecular Diagnostics, Inc. proceeds from stock plans for fiscal 2019 was $104.95K, a 25.52% decline from fiscal 2018.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2022-12-31 | $14.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $14.24K derived: sum of 2 quarters · filed 2023-03-30 | $37.57K 10-K · filed 2023-03-30 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $23.33K 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $23.33K 10-Q · filed 2022-08-12 | |||
| 2021-12-31 | $72.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $72.39K derived: sum of 2 quarters · filed 2023-03-30 | $125.83K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $53.44K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $53.44K 10-Q · filed 2022-08-12 | |||
| 2020-12-31 | $15.84K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $15.84K derived: sum of 2 quarters · filed 2022-03-29 | $40.98K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $25.13K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $25.13K 10-Q · filed 2021-08-12 | |||
| 2019-12-31 | $22.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $22.61K derived: sum of 2 quarters · filed 2021-03-25 | $104.95K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $82.34K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $82.34K 10-Q · filed 2020-08-11 | |||
| 2018-12-31 | $68.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $78.05K derived: sum of 2 quarters · filed 2020-03-25 | $140.91K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $72.86K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $62.86K 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $194.83K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $194.86K derived: sum of 2 quarters · filed 2019-03-07 | $266.55K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $27.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $71.72K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $71.69K 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $6.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $27.92K derived: sum of 2 quarters · filed 2018-03-23 | $174.67K 10-K · filed 2018-03-23 | |
| 2016-09-30 | $20.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $167.72K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $146.76K 10-Q · filed 2017-08-08 | |||
| 2015-12-31 | $20.00K 10-K · filed 2017-03-23 |